Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson’s disease
Open Access
- 8 April 2015
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 9, 97
Abstract
Parkinson’s disease (PD) is an incurable progressive neurodegenerative disorder. Clinical presentation of PD stems largely from the loss of dopaminergic neurons in the nigrostriatal dopaminergic pathway, motivating experimental strategies aimed at replacing dopaminergic innervation by cellular therapy. Transplantation of dopaminergic neurons derived from embryonic stem cells significantly improves motor functions in rodent and non-human primate models of PD. However, protocols to generate dopaminergic neurons from embryonic stem cells generally meet with low efficacy and high risk of teratoma development upon transplantation. To address these issues, we have pre-treated undifferentiated mouse embryonic stem cells (mESCs) with the DNA alkylating agent mitomycin C (MMC) before transplantation. MMC treatment of cultures prevented tumor formation in a 12-week follow-up after mESCs were injected in nude mice. In 6-OH-dopamine-lesioned mice, intrastriatal injection of MMC-treated mESCs markedly improved motor function without tumor formation for as long as 15 months. Furthermore, we show that halting mitotic activity of undifferentiated mESCs induces a four-fold increase in dopamine release following in vitro differentiation. Our findings indicate that treating mESCs with mitomycin C prior to intrastriatal transplant is an effective strategy that could be further investigated as a novel alternative for treatment of Parkinson's disease.Keywords
This publication has 42 references indexed in Scilit:
- Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinomaCancer Medicine, 2013
- Strategies for enrichment and selection of stem cell-derived tissue precursorsStem Cell Research & Therapy, 2012
- Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s diseaseNature, 2011
- Identification of a neuronal gene expression signature: role of cell cycle arrest in murine neuronal differentiation in vitroAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Transplantation of Neuronal-Primed Human Bone Marrow Mesenchymal Stem Cells in Hemiparkinsonian RodentsPLOS ONE, 2011
- ES cell-derived renewable and functional midbrain dopaminergic progenitorsProceedings of the National Academy of Sciences, 2011
- Elimination of tumorigenic stem cells from differentiated progeny and selection of definitive endoderm reveals a Pdx1+ foregut endoderm stem cell lineageStem Cell Research, 2011
- The ROCK Inhibitor Y-27632 Improves Recovery of Human Embryonic Stem Cells after Fluorescence-Activated Cell Sorting with Multiple Cell Surface MarkersPLOS ONE, 2010
- Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral TestJournal of Visualized Experiments, 2010
- Markers and Methods for Cell Sorting of Human Embryonic Stem Cell-Derived Neural Cell PopulationsStem Cells, 2007